GlaxoSmithKline
GSK
$35.10
Share price
0.17%
Change (1 day)
-19.07%
Change (1 year)
Categories
Revenue for GlaxoSmithKline (GSK)
Revenue in 2022 (TTM): $38.94 B
According to GlaxoSmithKline's latest financial reports the company's current revenue (TTM) is $38.94 B. In 2021 the company made a revenue of $46.44 B an increase over the years 2020 revenue that were of $43.66 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GlaxoSmithKline from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $38.94 B | -16.16% |
| 2021 | $46.44 B | 6.36% |
| 2020 | $43.66 B | 1.33% |
| 2019 | $43.09 B | 5.76% |
| 2018 | $40.74 B | 2.99% |
| 2017 | $39.56 B | 7.25% |
| 2016 | $36.89 B | 1.94% |
| 2015 | $36.19 B | -3.79% |
| 2014 | $37.61 B | -10.04% |
| 2013 | $41.81 B | -1.12% |
| 2012 | $42.28 B | -2.33% |
| 2011 | $43.29 B | -0.57% |
| 2010 | $43.54 B | -2.66% |
| 2009 | $44.73 B | 2.6% |
| 2008 | $43.59 B | -4.42% |
| 2007 | $45.61 B | 5.63% |
| 2006 | $43.18 B | 11.61% |
| 2005 | $38.69 B | 2.7% |
| 2004 | $37.67 B | 9.44% |
| 2003 | $34.42 B | 35.53% |
| 2002 | $25.40 B | 3.3% |
| 2001 | $24.59 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $51.82 B | 33.10% | 🇨🇭 Switzerland |
 Pfizer PFE | $100.33 B | 157.65% | 🇺🇸 USA |
 Sanofi SNY | $47.62 B | 22.30% | 🇫🇷 France |
 Merck MRK | $59.28 B | 52.24% | 🇺🇸 USA |
 AstraZeneca AZN | $44.35 B | 13.89% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $14.92 B | -61.67% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.72 B | -98.14% | 🇺🇸 USA |